Published in Medical Letter on the CDC and FDA, August 9th, 1999
The ability to use these markers for malaria transfection should facilitate the development of drug and vaccine targets, indicated Choukri Ben Mamoun and colleagues, Washington University School of Medicine, St. Louis, Missouri ("A Set of Independent Selectable Markers for Transfection of the Human Malaria Parasite Plasmodium falciparum," Proceedings of the National Academy of Sciences, July 20, 1999;96(15):8716-8720).
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.